Last reviewed · How we verify
Iron Succinate (FERROUS SUCCINATE)
At a glance
| Generic name | FERROUS SUCCINATE |
|---|---|
| Drug class | ferrous succinate |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
Common side effects
Drug interactions
- dolutegravir
- enoxacin
- levodopa
- levofloxacin
- levothyroxine sodium
- lomefloxacin
- minocycline
- moxifloxacin
- mycophenolate mofetil
- norfloxacin
- ofloxacin
Key clinical trials
- Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ） (PHASE4)
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery (PHASE4)
- Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients (PHASE4)
- Treatment of Non-Anemic Iron Deficiency in Pregnancy (NA)
- Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women (NA)
- A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors (PHASE3)
- Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |